skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Arthritis And Rheumatism remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis
Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

Bejarano, Victoria ; Quinn, Mark ; Conaghan, Philip G. ; Reece, Richard ; Keenan, Anne‐Maree ; Walker, David ; Gough, Andrew ; Green, Michael ; McGonagle, Dennis ; Adebajo, Ade ; Jarrett, Stephen ; Doherty, Sheelagh ; Hordon, Lesley ; Melsom, Richard ; Unnebrink, Kristina ; Kupper, Hartmut ; Emery, Paul

Arthritis and rheumatism, 2008-10, Vol.59 (10), p.1467-1474 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Development and validation of a composite disease activity score for juvenile idiopathic arthritis
Development and validation of a composite disease activity score for juvenile idiopathic arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and validation of a composite disease activity score for juvenile idiopathic arthritis

Consolaro, Alessandro ; Ruperto, Nicolino ; Bazso, Anna ; Pistorio, Angela ; Magni‐Manzoni, Silvia ; Filocamo, Giovanni ; Malattia, Clara ; Viola, Stefania ; Martini, Alberto ; Ravelli, Angelo

Arthritis and rheumatism, 2009-05, Vol.61 (5), p.658-666 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

Moreland, Larry W. ; O'Dell, James R. ; Paulus, Harold E. ; Curtis, Jeffrey R. ; Bathon, Joan M. ; St.Clair, E. William ; Bridges Jr, S. Louis ; Zhang, Jie ; McVie, Theresa ; Howard, George ; van der Heijde, Désirée ; Cofield, Stacey S.

Arthritis and rheumatism, 2012-09, Vol.64 (9), p.2824-2835

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Multicenter, randomized, double‐blind, controlled trial of treatment of active rheumatoid arthritis with T‐614 compared with methotrexate
Multicenter, randomized, double‐blind, controlled trial of treatment of active rheumatoid arthritis with T‐614 compared with methotrexate
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multicenter, randomized, double‐blind, controlled trial of treatment of active rheumatoid arthritis with T‐614 compared with methotrexate

Lu, Liang‐jing ; Bao, Chun‐de ; Dai, Min ; Teng, Jia‐lin ; Fan, Wei ; Du, Fang ; Yang, Nan‐ping ; Zhao, Yin‐huan ; Chen, Zhi‐wei ; Xu, Jian‐hua ; He, Pei‐gen ; Wu, Hua‐xiang ; Tao, Yi ; Zhang, Miao‐jia ; Han, Xing‐hai ; Li, Xing‐fu ; Gu, Jie‐ruo ; Li, Jian‐hua ; Yu, Hao

Arthritis and rheumatism, 2009-07, Vol.61 (7), p.979-987 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
5
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

van der Heijde, Désirée ; Tanaka, Yoshiya ; Fleischmann, Roy ; Keystone, Edward ; Kremer, Joel ; Zerbini, Cristiano ; Cardiel, Mario H. ; Cohen, Stanley ; Nash, Peter ; Song, Yeong‐Wook ; Tegzová, Dana ; Wyman, Bradley T. ; Gruben, David ; Benda, Birgitta ; Wallenstein, Gene ; Krishnaswami, Sriram ; Zwillich, Samuel H. ; Bradley, John D. ; Connell, Carol A.

Arthritis and rheumatism, 2013-03, Vol.65 (3), p.559-570

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
6
Steroid‐sparing effects of methotrexate in systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial
Steroid‐sparing effects of methotrexate in systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Steroid‐sparing effects of methotrexate in systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial

Fortin, Paul R. ; Abrahamowicz, Michal ; Ferland, Diane ; Lacaille, Diane ; Smith, C. Douglas ; Zummer, Michel

Arthritis and rheumatism, 2008-12, Vol.59 (12), p.1796-1804 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
7
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

Kremer, Joel M. ; Cohen, Stanley ; Wilkinson, Bethanie E. ; Connell, Carol A. ; French, Jonathan L. ; Gomez-Reino, Juan ; Gruben, David ; Kanik, Keith S. ; Krishnaswami, Sriram ; Pascual-Ramos, Virginia ; Wallenstein, Gene ; Zwillich, Samuel H.

Arthritis and rheumatism, 2012-04, Vol.64 (4), p.970-981

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
8
Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

Weinblatt, Michael E. ; Schiff, Michael ; Valente, Robert ; van der Heijde, Désirée ; Citera, Gustavo ; Zhao, Cathy ; Maldonado, Michael ; Fleischmann, Roy

Arthritis and rheumatism, 2013-01, Vol.65 (1), p.28-38

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double‐blind treatment phase of a randomized placebo‐controlled trial of tocilizumab safety and prevention of structural joint damage at one year
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double‐blind treatment phase of a randomized placebo‐controlled trial of tocilizumab safety and prevention of structural joint damage at one year
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double‐blind treatment phase of a randomized placebo‐controlled trial of tocilizumab safety and prevention of structural joint damage at one year

Kremer, Joel M. ; Blanco, Ricardo ; Brzosko, Marek ; Burgos‐Vargas, Ruben ; Halland, Anne‐Marie ; Vernon, Emma ; Ambs, Petra ; Fleischmann, Roy

Arthritis and rheumatism, 2011-03, Vol.63 (3), p.609-621

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
10
Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases
Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases

Rekedal, Laura R. ; Massarotti, Elena ; Garg, Rajesh ; Bhatia, Radhika ; Gleeson, Timothy ; Lu, Bing ; Solomon, Daniel H.

Arthritis and rheumatism, 2010-12, Vol.62 (12), p.3569-3573 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (36)

Data de Publicação 

De até
Refinar
  1. Antes de1980  (12)
  2. 1980Até1988  (38)
  3. 1989Até1996  (129)
  4. 1997Até2005  (162)
  5. Após 2005  (180)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.